Jump Financial’s GSK GSK Stock Holding History

Jump Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,997	Closed	-$461K	–	1941
2025 Q2	$461K	Buy	+11,997	New	+$458K	0.01%	1262
2024 Q3	–	Sell	-5,198	Closed	-$200K	–	1829
2024 Q2	$200K	Buy	+5,198	New	+$219K	﹤0.01%	1566
2021 Q2	–	Sell	-8,031	Closed	-$358K	–	1212
2021 Q1	$358K	Buy	+8,031	New	+$365K	0.03%	536
2020 Q4	–	Sell	-10,167	Closed	-$478K	–	1033
2020 Q3	$478K	Buy	+10,167	New	+$509K	0.1%	343

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jump Financial's GSK Position: Q3 2025 in Review

Jump Financial sold out of GSK (GSK) in Q3 2025, closing a stake of 11,997 shares — an estimated $461K sold.

Jump Financial first reported a position in GSK in Q3 2020 and held it in 4 quarters. The position peaked at $478K in Q3 2020. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Jump Financial reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Jump Financial sold 11,997 GSK shares in Q3 2025, an estimated $461K.
Jump Financial first reported a position in GSK in Q3 2020 and held it in 4 quarters.
Jump Financial's GSK position peaked at $478K in Q3 2020.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.